Results 151 to 158 of about 3,513 (158)

An investigation on the association between sodium glucose co‐transporter 2 inhibitors use and acute pancreatitis: A VigiBase study

Pharmacoepidemiology and Drug Safety, 2021
Cristina Mogosan, Camelia Bucşa, Andréea Farcas   +2 more
exaly  

Reporting of Acute Inflammatory Neuropathies with COVID-19 Vaccines: Subgroup Disproportionality Analyses in VigiBase

Vaccines, 2021
Alessandro Ceschi, Roberta Noseda, Raffaela Bertoli   +2 more
exaly  

Tumor necrosis factor inhibitor-induced pleuropericarditis: A retrospective evaluation using data from VigiBase

International Immunopharmacology, 2020
Qun-Ying Yue
exaly  

Bullous pemphigoid induced by dipeptidyl peptidase-4 (DPP-4) inhibitors: a pharmacovigilance-pharmacodynamic/pharmacokinetic assessment through an analysis of the vigibase®

Expert Opinion on Drug Safety, 2019
Ugo Moretti, Emilio Clementi, Mazhar F   +2 more
exaly  

Intravitreal Anti-VEGF Drugs and Signals of Dementia and Parkinson-Like Events: Analysis of the VigiBase Database of Spontaneous Reports

Frontiers in Pharmacology, 2020
Janet Sultana, Paola Maria Cutroneo, Francesca Morgante   +2 more
exaly  

Reports for Herbal Medicines in the Global Suspected ADR Database VigiBase

2022
Florence van Hunsel, Joanne Barnes, Lucie M Gattepaille   +2 more
exaly  

Pharmacodynamic and pharmacokinetic drug interactions reported to VigiBase, the WHO global individual case safety report database

European Journal of Clinical Pharmacology, 2011
exaly  

Characterization of second primary malignancies post CAR T-cell therapy: real-world insights from the two global pharmacovigilance databases of FAERS and VigiBase

EClinicalMedicine
Aimin Jiang, Quan Cheng, Rong Hu
exaly